HMS second quarter revenue increases 26% to $89.3 million

HMS (NASDAQ: HMSY) today announced its financial results for the second quarter of 2011.

For the quarter ended June 30, 2011 revenue increased 26% to $89.3 million, compared with $70.7 million for the same period a year ago. Net income for the quarter increased 36% to $12.4 million or $0.14 per diluted share post-split ($0.43 pre-split) compared to net income of $9.1 million or $0.11 per diluted share post-split ($0.32 pre-split) for the same period a year ago. The Company has previously announced a three-for-one stock split for shareholders of record on July 22, 2011, that will be distributed on August 16, 2011.

For the first half of 2011, revenue increased 27% to $171.8 million versus $135.7 million for the prior year. Net income for the first half was $22.2 million or $0.26 per diluted share post-split ($0.77 pre-split) versus net income of $16.7 million or $0.20 per diluted share post-split ($0.59 pre-split) for the prior year.

The Company has revised its 2011 guidance from $370.0 million in revenue and $0.58 in fully diluted GAAP EPS ($1.74 pre-split) to $372 million in revenue and $0.59 in fully diluted GAAP EPS post-split ($1.78 pre-split).

"In the first half of 2011, clients in all our markets sought cost-savings solutions from HMS at an unprecedented rate," remarked Bill Lucia, Chief Executive Officer. "We see the trend continuing as clients face the challenges associated with growing their programs and complying with healthcare reform legislation."

Lucia added, "We are revising full year revenue and GAAP EPS guidance for 2011 to reflect both increasing confidence in HMS's ability to deliver a strong finish this year, and a very promising pipeline for 2012."

Source:

HMS

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.